Filing Flows › Industrials › Senseonics Holdings (SENS)
Senseonics Holdings (SENS) earnings and revenue breakdown
Latest: Q2 2026 · 10-Q filed Aug 6, 2026 · Senseonics Holdings (SENS) Q2 2026 earnings results →
Q2 2026 Revenue up 118% year over year to $14.5M · 253¢ of every $1 of revenue lost · operating margin -248.5%
Senseonics Holdings made $14.5M in Q2 2026 (+118% Y/Y). Operating margin -248.5%, net loss $36.7M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 6, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $14.5M in Q2 2026, up 118% year over year and up 24% from the previous quarter.
Gross margin was 59.1%, up 12.2 points from Q2 2025. Operating costs exceeded revenue by $36.0M, an operating margin of -248.5%. Operating expenses grew 155% against revenue growth of 118%. The fastest-growing cost line was SG&A (+238%). The quarter ended with a net loss of $36.7M, wider than the previous quarter's $32.3M loss.
Operating cash flow was −$30.1M. Non-cash charges added back $548K of depreciation and amortization and $3.6M of share-based compensation. Working capital and other items added $2.5M. Capital expenditures of $217K exceeded it, leaving free cash flow of −$30.4M.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 10-Q | Aug 6, 2026 | $14.5M | +118% | -248.5% | −$36.7M | −$30.1M |
| Q1 2026 | 10-Q | May 7, 2026 | $11.7M | +87% | -271.9% | −$32.3M | −$32.0M |
| Q4 2025 | 10-K | Mar 2, 2026 | $14.3M | +72% | -146.8% | −$20.8M | −$18.0M |
| Q3 2025 | 10-Q | Nov 5, 2025 | $8.1M | +90% | -242.1% | −$19.5M | −$15.8M |
| Q2 2025 | 10-Q | Aug 6, 2025 | $6.6M | +37% | -215.4% | −$14.5M | −$9.3M |
| Q1 2025 | 10-Q | May 8, 2025 | $6.3M | +24% | -215.6% | −$14.3M | −$16.1M |
| Q4 2024 | 10-K | Mar 3, 2025 | $8.3M | +3% | -172.0% | −$15.5M | −$14.2M |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About Senseonics Holdings
We are a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (“CGM”) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Our implantable CGM system (“Eversense”), including Eversense E3 and Eversense 365 CGM systems are designed to continually and accurately measure glucose levels in people with diabetes via an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to twelve months in the case of Eversense 365 and six months in the case of Eversense E3, as compared to seven to 15 days for non-implantable CGM systems.
In its own words, from its 10-K, filed Mar 2, 2026.
Senseonics Holdings against its Industrial Instruments For Measurement, Display, and Control peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +118% against the peers' median +17%. Operating margin: -248.5% against the peers' median 21.3%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| SENS Senseonics Holdings | Q2 2026 | $14.5M | +118% | -248.5% |
| DHR Danaher | Q3 2026 | $6.6B | +8% | 19.0% |
| AME Ametek | Q3 2026 | $2.2B | +17% | 26.3% |
| ROP Roper Technologies | Q3 2026 | $2.2B | +8% | 28.7% |
| KEYS Keysight Technologies | Q3 FY26 | $1.8B | +36% | 25.0% |
| MKSI MKS | Q3 2026 | $1.4B | +43% | 23.1% |
| FTV Fortive | Q3 2026 | $1.1B | +8% | 21.3% |
| ST Sensata Technologies Holding | Q3 2026 | $1.0B | +8% | 17.5% |
| RAL Ralliant | Q3 2026 | $620M | +17% | 18.9% |
Source: Senseonics Holdings 10-Q on SEC EDGAR · CIK 1616543 · Industrial Instruments For Measurement, Display, and Control
13F: who owns SENS and who is buying
More on SENS
History
Every quarter: Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results · Q4 2024 results